ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 300289 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 300289; 2) Community: the network communities that were significantly associated with the response to NSC 300289; 3) Molecule: the relationships between components within communities and NSC 300289; 4) MDR: the compounds that were significantly associated with the NSC 300289.

NSC Compound Enrichment Correlation
NSC 709237 Camptothecin Derivative 0.00407837248037199 0.65727104
NSC 710464 AFP464 0.00407837248037199 0.1766303
NSC 728856 5,6-Dihydro-6-[3-(3-imidazolylpropyl)amino-1-propyl]-5,11-di oxo-11H-indeno[1,2-c]isoquinoline dihdrochloride 0.00407837248037199 0.5008448
NSC 731589 Null 0.00407837248037199 0.25010011
NSC 745689 3-Cyano-8-chloro-4-imino-2-methyl thio pyrimido[2,1-b]benzothiazole 0.00407837248037199 0.029883705
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.00407837248037199 0.69827889
NSC 10520 Null 0.00407837248037205 -0.21616144
NSC 287459 Cytarabine AY 0.00407837248037205 0.62555174
NSC 123140 Alanine, 3-[(.alpha.,.alpha.-di-p-tolylbenzyl)thio]- 0.0041872854493286 -0.075260477
NSC 663790 Null 0.0041872854493286 0.44051512
Total:92  Current:12    [First] [Prev] [Next] [Last]